89 phenotypes from 10 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fstl1Gt(P086B03)Wrst/Fstl1Gt(P086B03)Wrst involves: 129S2/SvPas * ICR	no abnormal phenotype detected	J:238836
Fstl1tm1.1Mvdh/Fstl1tm1.1Mvdh Tg(Myh6-cre)2182Mds/0 involves: 129S4/SvJae * C57BL/6 * FVB/N	abnormal coronary vessel morphology	J:177416
	abnormal heart septum morphology	J:177416
	cardiac fibrosis	J:177416
	cardiac hypertrophy	J:177416
	decreased angiogenesis	J:177416
	decreased cardiac muscle contractility	J:177416
	increased heart left ventricle size	J:177416
	increased heart left ventricle weight	J:177416
	increased heart weight	J:177416
	increased myocardial fiber size	J:177416
	increased response of heart to induced stress	J:177416
	pulmonary vascular congestion	J:177416
Fstl1tm1.1Ning/Fstl1tm1.1Ning involves: 129S4/SvJae * C57BL/6J * FVB/N	abnormal breathing pattern	J:171347
	abnormal bronchiole morphology	J:171347
	abnormal larynx morphology	J:171347
	abnormal lung development	J:171347
	abnormal lung epithelium morphology	J:171347
	abnormal lung morphology	J:171347
	abnormal neural tube morphology	J:171347
	abnormal pulmonary alveolar sac morphology	J:171347
	abnormal skeleton morphology	J:171347
	abnormal trachea morphology	J:171347
	abnormal tracheal cartilage morphology	J:171347
	abnormal tracheal ciliated epithelium morphology	J:171347
	abnormal type II pneumocyte morphology	J:171347
	cyanosis	J:171347
	decreased alveolar lamellar body number	J:171347
	decreased surfactant secretion	J:171347
	decreased tracheal cartilage ring number	J:171347
	decreased type I pneumocyte number	J:171347
	hydroureter	J:171347
	increased glycogen level	J:171347
	increased type II pneumocyte number	J:171347
	neonatal lethality, complete penetrance	J:171347
	primary atelectasis	J:171347
	pulmonary hyperplasia	J:171347
	trachea stenosis	J:171347
Fstl1tm1.1Nju/Fstl1tm1.1Nju involves: 129 * C57BL/6 * FVB/N	abnormal kidney pelvis morphology	J:187117
	abnormal ureter development	J:187117
	abnormal ureter morphology	J:187117
	abnormal ureter urothelium morphology	J:187117
	dilated ureter	J:187117
	hydronephrosis	J:187117
	hydroureter	J:187117
	kidney papillary atrophy	J:187117
	small kidney	J:187117
	ureter stenosis	J:187117
Fstl1tm1.2Mvdh/Fstl1+ involves: 129S4/SvJae * C57BL/6 * FVB	abnormal rib morphology	J:176532
	asymmetric sternocostal joints	J:176532
Fstl1tm1.2Mvdh/Fstl1tm1.2Mvdh involves: 129S4/SvJae * C57BL/6 * FVB	abnormal bronchiole morphology	J:176532
	abnormal cervical atlas morphology	J:176532
	abnormal cervical axis morphology	J:176532
	abnormal costal cartilage morphology	J:176532
	abnormal digit morphology	J:176532
	abnormal hindlimb stylopod morphology	J:176532
	abnormal hindlimb zeugopod morphology	J:176532
	abnormal lung lobe morphology	J:176532
	abnormal metacarpal bone morphology	J:176532
	abnormal pulmonary alveolus morphology	J:176532
	abnormal rib morphology	J:176532
	abnormal spine curvature	J:176532
	abnormal tracheal cartilage morphology	J:176532
	absent patella	J:176532
	absent sesamoid bone of gastrocnemius	J:176532
	asymmetric sternocostal joints	J:176532
	bowed fibula	J:176532
	camptomelia	J:176532
	cyanosis	J:176532
	decreased bone ossification	J:176532
	fused phalanges	J:176532
	lordokyphosis	J:176532
	perinatal lethality, complete penetrance	J:176532
	primary atelectasis	J:176532
	respiratory distress	J:176532
Fstl1tm1Ajn/Fstl1tm1Ajn B6.Cg-Fstl1tm1Ajn	abnormal lung hysteresivity	J:322116
	abnormal lung volume	J:322116
	abnormal respiratory system physiology	J:322116
	decreased lung elastance	J:322116
	emphysema	J:322116
	increased lung apoptosis	J:322116
	increased lung compliance	J:322116
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H	decreased fasting circulating glucose level	J:211773
	decreased neutrophil cell number	J:211773
	impaired glucose tolerance	J:211773
	increased circulating cholesterol level	J:211773
	increased circulating HDL cholesterol level	J:211773
	increased lymphocyte cell number	J:211773
Fstl1tm1Nju/Fstl1tm1Nju Tg(Scn10a-cre)1Rkun/0 involves: 129 * C57BL/6 * DBA	abnormal action potential	J:188549
	abnormal dorsal root ganglion morphology	J:188549
	decreased chemical nociceptive threshold	J:188549
	decreased thermal nociceptive threshold	J:188549
	hyperresponsive to tactile stimuli	J:188549
	increased excitatory postsynaptic current frequency	J:188549
Fstl1tm2.1(cre/ERT2)Mvdh/Fstl1+ involves: 129P2/OlaHsd * C57BL/6	abnormal rib morphology	J:176532
	asymmetric sternocostal joints	J:176532
Fstl1tm2.1(cre/ERT2)Mvdh/Fstl1tm2.1(cre/ERT2)Mvdh involves: 129P2/OlaHsd * C57BL/6	abnormal bronchiole morphology	J:176532
	abnormal costal cartilage morphology	J:176532
	abnormal lung lobe morphology	J:176532
	abnormal pulmonary alveolus morphology	J:176532
	abnormal rib morphology	J:176532
	abnormal tracheal cartilage morphology	J:176532
	asymmetric sternocostal joints	J:176532
	camptomelia	J:176532
	cyanosis	J:176532
	fused phalanges	J:176532
	perinatal lethality, complete penetrance	J:176532
	primary atelectasis	J:176532
	respiratory distress	J:176532
Tg(Ckm-Fstl1)#Mvdh/0 involves: C57BL/6	abnormal coronary vessel morphology	J:177416
	cardiac fibrosis	J:177416
	decreased cardiac muscle contractility	J:177416
	decreased response of heart to induced stress	J:177416
	increased angiogenesis	J:177416
	increased heart left ventricle weight	J:177416
	increased heart weight	J:177416
	increased myocardial fiber size	J:177416